EFXT vs NOV: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
NOV is the larger of the two ($6.93B market cap): the incumbent the market prices for continued execution (14.96x forward earnings, beta 0.92). EFXT is the smaller challenger ($2.62B), cheaper on forward earnings (11.32x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
EFXT vs NOV: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | EFXT | NOV | What it tells you |
|---|---|---|---|
| Market cap | $2.62B | $6.93B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 11.32 | 14.96 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 48.68 | 71.96 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 2.08 | 0.92 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 61% of range | 78% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.24 | 1.11 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: EFXT is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how EFXT and NOV affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. EFXT and NOV share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined EFXT and NOV exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Enerflex (EFXT) do?
Enerflex Ltd. is a Calgary-based provider of natural gas compression, processing and treating infrastructure, listed on the NYSE as EFXT and on the Toronto Stock Exchange as EFX. It reports in three geographic segments (North America, Latin America and the Eastern Hemisphere) and operates three product lines. Engineered Systems designs and fabricates gas-handling equipment to customer order and books revenue as projects are executed. Energy Infrastructure owns and operates compression and processing assets under multi-year contracts and collects a fee. After-Market Services maintains the installed base. In the second quarter of 2026, Energy Infrastructure and After-Market Services together produced about 69% of consolidated gross margin before depreciation, and the company puts recurring sources at roughly 65% of adjusted gross margin through a full cycle. Enerflex is a Canadian issuer but reports in US dollars, and it declares its dividend in Canadian dollars, so a US shareholder holds a USD-reporting company that pays a CAD distribution.
What does NOV Inc (NOV) do?
NOV Inc, known as National Oilwell Varco until its 2021 rebrand, is a Houston-based designer and manufacturer of equipment, technology, and components used across the oil and gas industry. The company operates through two reporting segments: Energy Equipment, which builds capital equipment for offshore rigs, subsea production, floating and land drilling systems, wind installation vessels, and process and flow technologies, and Energy Products and Services, which supplies drill pipe, downhole tools, drill bits, coiled tubing, composite pipe, and aftermarket parts and repair. NOV sells into a global customer base of drilling contractors, national and international oil companies, and service firms, and increasingly positions parts of its portfolio toward offshore wind and industrial process markets.
EFXT vs NOV: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- EFXT drivers: The deleveraging cycle is finished; Recurring margin from infrastructure and services.
- NOV drivers: Offshore and International Equipment Cycle; Backlog and Book-to-Bill Visibility.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Engineered Systems bookings depend on customer capital budgets, which are driven by natural gas prices and LNG project timing, so a 1.6x book-to-bill quarter tells you nothing about the next one and revenue has already been declining year over year. For NOV, the largest risk is the oil and gas capital-spending cycle: when operators and drilling contractors cut budgets, demand for NOV's equipment, drill pipe, and aftermarket parts falls quickly, and global drilling activity already declined about 7% in 2025.
EFXT or NOV: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick EFXT if you believe its drivers more; NOV if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the EFXT and NOV guides.
EFXT vs NOV: the full fundamentals
EFXT. Figures are approximate, tied to the asOf date, and reported in US dollars even though Enerflex is a Canadian issuer whose quarterly dividend of C$0.0425 is declared in Canadian dollars. The multiple looks undemanding against annualized EBITDA, but two things complicate it: earnings are still falling year over year, and the pending sale of most Asia Pacific operations to INNIO will change the revenue and EBITDA base before the year is out. Return on capital employed was 15.4% in Q2 2026 after a record 17.3% in Q1, which is a more useful read on this business than the P/E because so much of the asset base is owned, depreciating infrastructure.
NOV. NOV's full-year 2025 revenue of roughly $8.74 billion was down about 1% year over year, a resilient outcome against a 7% drop in global drilling activity, driven by offshore capital-equipment strength in the Energy Equipment segment. The unusually high trailing P/E of roughly 70x to 75x reflects a low denominator, with 2025 net income of only $145 million (~$0.39 per diluted share), so the forward multiple near 18x and cash-flow metrics are more informative than trailing earnings. Q1 2026 was soft, with EPS of $0.05 missing consensus of $0.16 amid Middle East disruptions, and management guided 2026 to slightly lower revenue with EBITDA in line to modestly below 2025.
Headline figures (approximate, August 2026): EFXT shows revenue (ttm) ~$2.57 billion (Q2 2026 was ~$582 million, down from ~$615 million a year earlier), adjusted ebitda ~$128 million in Q2 2026, ~$265 million across the first half of 2026, net income (q2 2026) ~$30 million, or ~$0.25 per diluted share (versus ~$60 million and ~$0.49 a year earlier), engineered systems backlog ~$1.45 billion at June 30, 2026, on ~$488 million of quarterly bookings (1.6x book-to-bill); NOV shows revenue (fy 2025) ~$8.74 billion, revenue (q1 2026) ~$2.05 billion, adjusted ebitda (fy 2025) ~$1.03 billion, net income (fy 2025) ~$145 million (~$0.39 diluted EPS).
The bottom line: EFXT vs NOV
EFXT and NOV are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined EFXT and NOV exposure against your real portfolio. It is not an investment adviser.
Wondering how EFXT or NOV fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Enerflex with AI
Connect the broker you already use and ask Walnut's AI how EFXT fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between EFXT and NOV?
+
Enerflex Ltd. NOV Inc, known as National Oilwell Varco until its 2021 rebrand, is a Houston-based designer and manufacturer of equipment, technology, and components used across the oil and gas industry. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is EFXT or NOV the better stock?
+
Neither is universally better. NOV is the larger incumbent; EFXT is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, EFXT or NOV?
+
On forward P/E (as of August 2026), EFXT trades at 11.32x and NOV at 14.96x, so EFXT is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both EFXT and NOV?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of EFXT vs NOV?
+
EFXT: Engineered Systems bookings depend on customer capital budgets, which are driven by natural gas prices and LNG project timing, so a 1.6x book-to-bill quarter tells you nothing about the next one and revenue has already been declining year over year. Contract compression growth is cash out today against contracted cash in over years, so a fleet build funded into a softening rate environment would hurt returns well after the capex is committed. Geographic exposure carries real country risk: Latin America and Eastern Hemisphere operations bring currency, receivable-collection and contract-enforcement issues that a purely North American peer does not face. The APAC sale to INNIO is subject to regulatory approvals and has not closed, so the post-divestiture earnings base is still an estimate rather than a reported figure. Finally, this is a roughly $2.6 billion company whose shareholder base and dividend sit in Canadian dollars while it reports in US dollars, which means US holders take a currency mismatch on income and trade a US listing that is less liquid than the domestic compression peers. NOV: The largest risk is the oil and gas capital-spending cycle: when operators and drilling contractors cut budgets, demand for NOV's equipment, drill pipe, and aftermarket parts falls quickly, and global drilling activity already declined about 7% in 2025. Q1 2026 results underscored the fragility, with revenue of $2.05 billion, adjusted EBITDA of $177 million, and EPS of just $0.05 that missed estimates, hurt by Middle East conflict-related disruptions. Full-year 2026 guidance calls for slightly lower revenue and EBITDA in line to slightly below 2025, with results weighted to the second half. A declining backlog and book-to-bill below 100%, geopolitical instability in key regions, and a slower-than-expected offshore recovery all add uncertainty, and net income of $145 million in 2025 leaves the trailing valuation sensitive to any further earnings weakness.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell EFXT or NOV; figures are approximate and dated (as of August 2026). Verify current data before investing.